If The Data's Good, Use It--Regardless Of The Source

Earlier this year, the Environmental Protection Agency became embroiled in controversy over the question of using results from Nazi scientists. An agency report had included data from experiments conducted on French prisoners investigating the toxicity of phosgene. Once the fact became known, the response was swift; 22 EPA scientists petitioned the agency administrator, Lee Thomas, to expunge the offending data from the report, and Thomas obligingly complied. When I read about the ruckus in t

Written byAlan Nixon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Earlier this year, the Environmental Protection Agency became embroiled in controversy over the question of using results from Nazi scientists. An agency report had included data from experiments conducted on French prisoners investigating the toxicity of phosgene. Once the fact became known, the response was swift; 22 EPA scientists petitioned the agency administrator, Lee Thomas, to expunge the offending data from the report, and Thomas obligingly complied.

When I read about the ruckus in the April 1,1988, issue of Science, I wondered at first, because of the date, if it was some sort of a spoof. But it wasn’t—and I felt that there were some things that needed saying. So in the Nick Nacks column in the May issue of my newsletter, the Vortex (a publication of the California Section of the American Chemical Society), I wrote, “In view of the fact that there is practically no human dose-response data ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies